IB Net Payout Yields Model

Tilray Brands: Not A Good U.S. Legalization Play

  • Tilray Brands fell after reporting another weak quarter for the period ending in August.
  • The Canadian cannabis stock had rallied on hopes the U.S. would finally legalized weed.
  • The stock isn't the best way to play U.S. legalization with a whole host of smaller U.S. MSOs the ones likely to see the biggest gains.
  • This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » 

 Tilray Brands (NASDAQ:TLRY) has been one of the most loved cannabis stocks, yet the company hasn't produced any results warranting the love. The Canadian LP reported another weak quarter following a rally on the marijuana reforms announced by President Biden. My investment thesis remains Bearish on the stock, as investors continue to rush into the stock on unwarranted hype on U.S. legalization hopes.

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 


Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

C3.ai: Out Of Steam (Rating Downgrade)

Archer Aviation: Promising Developments